Bridge Medicines biotech company launched in partnership with Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine, Takeda Pharmaceutical Company Ltd. and healthcare investment firms Bay City Capital and Deerfield Management. Our mission is to move breakthrough research to the patient by bringing the best in modern drug discovery to the service of academic medicine.
Company Details
- Employees
- 2
- Founded
- 2016
- Address
- New York, New York
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.bridgemedicines.com
- Keywords
- of academic medicine..
- HQ
- New York, New York
Bridge Medicines Llc Questions
Bridge Medicines Llc's website is http://www.bridgemedicines.com
Bridge Medicines Llc's LinkedIn profile is https://www.linkedin.com/company/bridge-medicines-llc
Bridge Medicines Llc has
2 employees.
View email and phone details for 2
employees at Bridge Medicines Llc.
Bridge Medicines Llc's industry is
Pharmaceutical Manufacturing
Bridge Medicines Llc's top competitors are
Aviadobio,
Io Biotech,
Cspc Pharmaceutical Group,
Crinetics Pharmaceuticals,
Evaxion A/s,
Galecto, Inc.,
Deerfield Management,
Mestag Therapeutics,
Bicara Therapeutics,
Symphogen.
Bridge Medicines Llc's categories are Pharmaceutical Manufacturing
Bridge Medicines Llc's founding year is 2016
